BR112012001959A2 - comprimido,e, método para reproduzir um comprimido - Google Patents
comprimido,e, método para reproduzir um comprimidoInfo
- Publication number
- BR112012001959A2 BR112012001959A2 BR112012001959A BR112012001959A BR112012001959A2 BR 112012001959 A2 BR112012001959 A2 BR 112012001959A2 BR 112012001959 A BR112012001959 A BR 112012001959A BR 112012001959 A BR112012001959 A BR 112012001959A BR 112012001959 A2 BR112012001959 A2 BR 112012001959A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- reproducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009175695 | 2009-07-28 | ||
PCT/JP2010/062568 WO2011013639A1 (ja) | 2009-07-28 | 2010-07-27 | 錠剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012001959A2 true BR112012001959A2 (pt) | 2016-03-15 |
Family
ID=43529294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012001959A BR112012001959A2 (pt) | 2009-07-28 | 2010-07-27 | comprimido,e, método para reproduzir um comprimido |
Country Status (23)
Country | Link |
---|---|
US (1) | US20120129878A1 (pt) |
EP (1) | EP2460523B1 (pt) |
JP (1) | JP5732394B2 (pt) |
KR (1) | KR20120039046A (pt) |
CN (1) | CN102548556A (pt) |
AU (1) | AU2010279171A1 (pt) |
BR (1) | BR112012001959A2 (pt) |
CA (1) | CA2769177A1 (pt) |
CL (1) | CL2012000182A1 (pt) |
CO (1) | CO6612226A2 (pt) |
CR (1) | CR20120061A (pt) |
EA (1) | EA201270204A1 (pt) |
EC (1) | ECSP12011699A (pt) |
IL (1) | IL217560A0 (pt) |
IN (1) | IN2012DN00954A (pt) |
MA (1) | MA33539B1 (pt) |
MX (1) | MX2012001284A (pt) |
PE (1) | PE20120919A1 (pt) |
SG (1) | SG178062A1 (pt) |
TN (1) | TN2012000031A1 (pt) |
TW (1) | TW201106991A (pt) |
WO (1) | WO2011013639A1 (pt) |
ZA (1) | ZA201200761B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5874545B2 (ja) * | 2011-06-20 | 2016-03-02 | アステラス製薬株式会社 | 経口投与用医薬組成物 |
UY34847A (es) | 2012-06-05 | 2014-01-31 | Takeda Pharmaceutical | Preparacion sólida |
CN103768071B (zh) * | 2012-10-23 | 2016-08-17 | 中国医药工业研究总院 | 一种治疗糖尿病的口服制剂 |
CN103877054B (zh) * | 2012-12-21 | 2016-05-25 | 北大方正集团有限公司 | 一种苯甲酸阿格列汀片剂及其制备方法 |
CN105078974A (zh) * | 2014-05-23 | 2015-11-25 | 深圳信立泰药业股份有限公司 | 一种阿利沙坦酯固体分散体及药物组合物 |
US20160331689A1 (en) * | 2015-05-12 | 2016-11-17 | SE Tylose USA, Inc. | Aqueous enteric coating composition |
CN105596341B (zh) * | 2016-03-14 | 2018-08-10 | 石家庄四药有限公司 | 一种琥珀酸曲格列汀固体制剂及制备方法 |
CN109069455B (zh) | 2016-05-10 | 2020-10-09 | 日本脏器制药株式会社 | 对乙酰氨基酚制剂的制造方法 |
CN114122219A (zh) * | 2020-08-28 | 2022-03-01 | 群创光电股份有限公司 | 发光单元 |
CN116763752B (zh) * | 2023-08-24 | 2023-11-17 | 北京福元医药股份有限公司 | 一种阿卡波糖片剂及其制备方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
EP0862562B1 (en) | 1995-09-13 | 2001-07-04 | Takeda Chemical Industries, Ltd. | Benzoxazepine compounds, their production and use as lipid lowering agents |
JP2711528B2 (ja) * | 1995-12-20 | 1998-02-10 | 大洋薬品工業株式会社 | ロキソプロフェン製剤 |
AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
WO2002006234A1 (fr) | 2000-07-17 | 2002-01-24 | Takeda Chemical Industries, Ltd. | Derives de sulfonate, procede de production et utilisation de ces derives |
CN1731994A (zh) | 2002-11-01 | 2006-02-08 | 武田药品工业株式会社 | 预防或治疗神经病的药剂 |
AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
EP1564213A4 (en) | 2002-11-22 | 2009-05-27 | Takeda Pharmaceutical | IMIDAZOLE DERIVATIVES, PROCESS FOR THE PRODUCTION AND USE THEREOF |
US7820837B2 (en) | 2003-05-30 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
US7534887B2 (en) | 2003-09-30 | 2009-05-19 | Takeda Pharmaceutical Company Limited | Thiazoline derivative and use of the same |
US7820673B2 (en) | 2003-12-17 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same, and use |
TW200523247A (en) | 2003-12-25 | 2005-07-16 | Takeda Pharmaceutical | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
JP4855777B2 (ja) | 2003-12-26 | 2012-01-18 | 武田薬品工業株式会社 | フェニルプロパン酸誘導体 |
EP1726580A4 (en) | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
CN102134231B (zh) | 2004-03-15 | 2020-08-04 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
JP4859665B2 (ja) | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
JP4919252B2 (ja) * | 2004-08-05 | 2012-04-18 | 株式会社明治 | 顆粒状製剤及びその製造方法 |
JP5094394B2 (ja) | 2005-04-20 | 2012-12-12 | 武田薬品工業株式会社 | 縮合複素環化合物 |
EP1897558B1 (en) * | 2005-06-09 | 2013-09-04 | Norgine BV | Solid preparation of 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one |
JPWO2007013694A1 (ja) | 2005-07-29 | 2009-02-12 | 武田薬品工業株式会社 | フェノキシアルカン酸化合物 |
EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
BRPI0615150A2 (pt) | 2005-08-10 | 2017-06-20 | Takeda Pharmaceuticals Co | agente para a profilaxia ou tratamento de diabete, sensibilizador de insulina, composto, pró-droga, agente farmacêutico, e, uso do composto ou um sal do mesmo ou uma pró-droga do mesmo |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
JP2007211005A (ja) * | 2006-01-16 | 2007-08-23 | Ono Pharmaceut Co Ltd | 固形製剤用組成物および固形製剤 |
WO2008001931A2 (en) | 2006-06-27 | 2008-01-03 | Takeda Pharmaceutical Company Limited | Fused cyclic compounds |
ATE522216T1 (de) | 2006-09-13 | 2011-09-15 | Takeda Pharmaceutical | Verwendung von 2-6-(3-amin-piperidin-1-yl)-3- methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1- ylmethyl-4-fluor-benzonitril zur behandlung von diabetes, krebs, autoimmunerkrankungen und hiv- infektionen |
WO2008047821A1 (fr) | 2006-10-18 | 2008-04-24 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique fusionné |
US8410087B2 (en) | 2006-10-19 | 2013-04-02 | Takeda Pharmaceutical Company Limited | Indole compound |
US20100016396A1 (en) | 2007-01-29 | 2010-01-21 | Hiroshi Imoto | Pyrazole compound |
US8697125B2 (en) * | 2007-02-01 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Tablet preparation without causing a tableting trouble |
AU2008215490A1 (en) | 2007-02-09 | 2008-08-21 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of PPAR-gamma |
PE20090015A1 (es) * | 2007-03-13 | 2009-01-30 | Takeda Pharmaceutical | Preparacion solida |
WO2008136428A1 (ja) | 2007-04-27 | 2008-11-13 | Takeda Pharmaceutical Company Limited | 含窒素5員複素環化合物 |
US20110301155A1 (en) | 2007-06-19 | 2011-12-08 | Tsuneo Yasuma | Indazole compounds for activating glucokinase |
US8400391B2 (en) | 2008-01-10 | 2013-03-19 | Honeywell International Inc. | Method and system for improving dimming performance in a field sequential color display device |
-
2010
- 2010-07-27 AU AU2010279171A patent/AU2010279171A1/en not_active Abandoned
- 2010-07-27 KR KR1020127005105A patent/KR20120039046A/ko not_active Application Discontinuation
- 2010-07-27 EA EA201270204A patent/EA201270204A1/ru unknown
- 2010-07-27 CA CA2769177A patent/CA2769177A1/en not_active Abandoned
- 2010-07-27 EP EP10804385.2A patent/EP2460523B1/en active Active
- 2010-07-27 BR BR112012001959A patent/BR112012001959A2/pt not_active Application Discontinuation
- 2010-07-27 WO PCT/JP2010/062568 patent/WO2011013639A1/ja active Application Filing
- 2010-07-27 TW TW099124649A patent/TW201106991A/zh unknown
- 2010-07-27 PE PE2012000104A patent/PE20120919A1/es not_active Application Discontinuation
- 2010-07-27 MX MX2012001284A patent/MX2012001284A/es not_active Application Discontinuation
- 2010-07-27 CN CN2010800431623A patent/CN102548556A/zh active Pending
- 2010-07-27 US US13/261,160 patent/US20120129878A1/en not_active Abandoned
- 2010-07-27 IN IN954DEN2012 patent/IN2012DN00954A/en unknown
- 2010-07-27 JP JP2011524778A patent/JP5732394B2/ja active Active
- 2010-07-27 SG SG2012003984A patent/SG178062A1/en unknown
-
2012
- 2012-01-16 IL IL217560A patent/IL217560A0/en unknown
- 2012-01-20 TN TNP2012000031A patent/TN2012000031A1/en unknown
- 2012-01-23 CL CL2012000182A patent/CL2012000182A1/es unknown
- 2012-01-31 ZA ZA2012/00761A patent/ZA201200761B/en unknown
- 2012-02-08 CR CR20120061A patent/CR20120061A/es unknown
- 2012-02-24 CO CO12032481A patent/CO6612226A2/es not_active Application Discontinuation
- 2012-02-27 MA MA34653A patent/MA33539B1/fr unknown
- 2012-02-28 EC ECSP12011699 patent/ECSP12011699A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2012000182A1 (es) | 2012-10-12 |
WO2011013639A1 (ja) | 2011-02-03 |
PE20120919A1 (es) | 2012-08-13 |
KR20120039046A (ko) | 2012-04-24 |
CR20120061A (es) | 2012-03-06 |
ECSP12011699A (es) | 2012-03-30 |
AU2010279171A1 (en) | 2012-03-01 |
US20120129878A1 (en) | 2012-05-24 |
CO6612226A2 (es) | 2013-02-01 |
TN2012000031A1 (en) | 2013-09-19 |
EP2460523A4 (en) | 2014-02-26 |
SG178062A1 (en) | 2012-03-29 |
IL217560A0 (en) | 2012-02-29 |
IN2012DN00954A (pt) | 2015-04-10 |
MX2012001284A (es) | 2012-03-26 |
MA33539B1 (fr) | 2012-08-01 |
CA2769177A1 (en) | 2011-02-03 |
EP2460523A1 (en) | 2012-06-06 |
TW201106991A (en) | 2011-03-01 |
ZA201200761B (en) | 2013-05-29 |
EP2460523B1 (en) | 2017-01-04 |
EA201270204A1 (ru) | 2012-08-30 |
CN102548556A (zh) | 2012-07-04 |
JPWO2011013639A1 (ja) | 2013-01-07 |
JP5732394B2 (ja) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012001959A2 (pt) | comprimido,e, método para reproduzir um comprimido | |
BR112014008603A2 (pt) | tablete, e, método para produzir um tablete | |
BRPI1012752A2 (pt) | método e aparelho para detectar um fenômeno físico. | |
BRPI1014151A2 (pt) | dispositivo electrocrómico e método para a sua produção. | |
BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
BRPI0908192A2 (pt) | Dispositivo funcional, e, método para produzir um dispositivo funcional | |
BR112014003798A2 (pt) | método para fabricar um composto, e, composto | |
BRPI1009655A2 (pt) | método e método para preparar um poliéster | |
BRPI1007266A2 (pt) | aparelhos e métodos para separação, e para separação e transferência de pastilha. | |
BR112013005407A2 (pt) | atuador e método para a fabricação do atuador | |
BR112013022559A2 (pt) | cartão, e, método para fabricar um cartão | |
BRPI0906022A2 (pt) | Dispositivo funcional, e, método para fabricar um dispositivo funcional | |
BRPI1014035A2 (pt) | método para contracepção. | |
BRPI1008304A2 (pt) | pistão, e, método para construir um pistão | |
BR112013012364A2 (pt) | visor, e, método para fabricar um visor | |
BRPI0916787A2 (pt) | artigo, e, método para fabricar um artigo | |
BRPI0924664A2 (pt) | eletrodo ,e ,método para construir um eletrodo. | |
BR112012014075A2 (pt) | aparelho, sistema e método para empregar um ups. | |
BR112012009974A2 (pt) | método para produzir grândulos que compreendem um perticida | |
BR112012002945A2 (pt) | método e dispositivo para secagem de um gás. | |
EP2672395A4 (en) | TRANSLITTERATION DEVICE, PROGRAM, RECORDING MEDIUM, AND METHOD | |
BR112012002861A2 (pt) | método e dispositivo para a provisão de informações complementares | |
EP2713555A4 (en) | DATA CONFIGURATION METHOD AND DEVICE, AND METHOD OF RESOLUTION AND DEVICE FOR DATA CONFIGURATION | |
BR112014013188A2 (pt) | documento de segurança, e método para fabricar um documento de segurança | |
BR112012010861A2 (pt) | dispositivo livre de congelamento e método para produzir um dispositivo livre de congelamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |